S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil.

In conclusion, S-1 monotherapy provided a mild response rate and overall survival, and a favorable toxicity profile in the second line setting after the first line failure to cisplatin and fluorouracil combination.
PMID: 25031751 [PubMed - in process]

Source: International Journal of Clinical and Experimental Pathology - July 19, 2014 Category: Pathology Authors: Lv F, Liu X, Wang B, Guo H, Li J, Shen L, Jin M Tags: Int J Clin Exp Pathol Source Type: research